Expertise Partner

SCARLETRED is a digital health company with a unique AI focus in Dermatology. We develop and deliver revolutionary software products and services to biopharma, medical experts, and clinical research organisations. Our certified and ICH-GCP compliant mobile medical device software Scarletred® is the first digital solution solving the problem of lacking standardization and subjective visual skin assessment in pre-clinical, clinical, and post-marketing studies. It enables on-site and home-based monitoring and analysis of skin drug effects. The scalable platform works infrastructure as well as location independent. It reduces development time/cost and increases patient compliance. We are operating worldwide from our offices in Vienna (Austria) and Cambridge (USA).


Innovation Partner

Monasterium Laboratory is one of the leading CROs in hair & skin research with advanced expertise in translational research and (pre-)clinical services for dermatological, therapeutic, and nutraceutical applications. Based on our excellent academic research background, we provide state-of-the-art in vitro cell models, ex vivo organ culture models, in vivo humanized animal models and cutting-edge techniques. We develop tailor-made assays for answering specific research questions to meet client’s needs. We collaborate with industry in joint research projects to identify new targets/products for the care and treatment of skin and hair follicles and their diseases.

Untitled design (9)

Innovation Partner

RaDes GmbH is convinced that topical formulation development is full of opportunities to enable challenging development projects and improve existing products. With industry-leading expertise in semi-solid formulations and advanced analytical capabilities, we have demonstrated that topical formulations are not a matter of "art" or "trial and error", but can be designed rationally and systematically. We offer development services in formulation, analytics and performance testing. RaDes is based in Hamburg, Germany and serves customers in many European countries and the USA.

download (3)

Innovation Partner

NUVISAN is a fully integrated Contract Research Organization with a 40- year track record of serving clients’ needs in early and clinical development for pharmaceutical and biotech companies, academic institutes and CROs. The company’s fully integrated value chain of GxP services from early research to clinical trials phase II improves efficiency, compliance, and data
quality to safely and effectively bring your products to the market.


Innovation Partner

MedPharm is the world’s leading contract provider of topical and transdermal formulation development and manufacturing services. MedPharm’s experts specialize in reducing risk and accelerating development times for generic and proprietary pharmaceutical customers through cost-effective and industry-leading performance testing models. Well-established as the global leader in dermal and transdermal product development, MedPharm also offers innovative solutions for airway, ophthalmic, otic, ungual, and other topical preparations. With locations in both the US and the UK, MedPharm is the CDMO of choice for developers around the globe


Innovation Partner

At Dermagnostix, translational biomarker assessment meets cutting-edge microfluidics technology to automate complex diagnostic assays. Our LabDisk tests evaluate skin at the gene level to deliver objective and precise information on a patient’s individual molecular signature to guide clinical decision-making. Each disposable LabDisk contains all the reagents required for biomarker analysis and is used in combination with the LabDisk Analyzer, a fully automated portable laboratory. PsorX (CE-IVD) is the first in-class molecular test for differential diagnosis of psoriasis and eczema.


Exhibition Partner

Eurofins Bioskin is a leading CRO with unique capabilities for both early and late phase dermatological clinical trials. Recognized by global companies as a valuable partner in studies for drugs, medical devices, food supplements and advanced cosmetics/aesthetics. Since 1992, Eurofins Bioskin offers early phase safety and Proof-of Concept studies, global Phase II – IV trials for NCEs, new formulations with known actives as well as consulting in the field of dermatology.